Dr. Marta-Lisette Vares from Chemestmed, an innovative biotechnology company based in Tartu, Estonia recently visited the Latvian Institute of Organic Synthesis (LIOS) to gain hands-on experience in nuclear magnetic resonance (NMR) spectroscopy. During her visit, she was trained on the use of high-field NMR instrumentation to investigate protein–ligand interactions — a key method for understanding molecular mechanisms in drug discovery.

Dr. Vares visit initiated new collaboration between Chemestmed and the HORIZON-WIDERA-2023 Twinnining project MR Latvia in LIOS.

This collaboration marks another important step toward strengthening industry–research partnerships in the Baltic region, fostering knowledge exchange and advancing the use of state-of-the-art NMR technologies for biomedical research.

 We look forward to a productive and long-term collaboration with Chemestmed, supporting their efforts to accelerate innovative therapeutic development.

NMR instruments in LIOS are a part of Instruct-LV Research Site infrastructure.

The Latvian Biomedical Research and Study Centre is implementing project No. 1.1.1.5/3/24/I/006 “Development of Latvia’s research potential by strengthening the integration of the Latvian Biomedical Research and Study Centre into European infrastructures and scientific networks” within which the Latvian National Partnership Plan for the Integrated Structural Biology Infrastructure (Instruct-ERIC) is being implemented.